Wells Fargo & Company Nuwellis, Inc. Transaction History

Wells Fargo & Company

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.56 - $2147.95 $19 - $75,178	-35 Reduced 33.33%	70 $0
Q2 2022 Aug 12, 2022	BUY	$0.48 - $1.12 $2 - $5	5 Added 5.0%	105 $0
Q1 2022 May 16, 2022	BUY	$0.85 - $1.27 $33 - $49	39 Added 63.93%	100 $0
Q4 2021 Feb 14, 2022	BUY	$1.13 - $2.26 $27 - $54	24 Added 64.86%	61 $0
Q3 2021 Nov 15, 2021	SELL	$2.12 - $4.6 $10 - $23	-5 Reduced 11.9%	37 $0
Q2 2021 Aug 16, 2021	BUY	$3.53 - $5.98 $148 - $251	42 New	42 $0

Ticker NUWE
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,531,600
Market Cap $51.1M
Description
Nuwellis, Inc., a medical device company, focuses on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy. The company's products are the Aquadex FlexFlow and Aquadex SmartFlow systems, which are indicated for the treatment of patients suffering from fluid overload who have failed diuretics. Its Aquadex ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.